• Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Responseā„¢)
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • Familial Adenomatous Polyposis (APC) Gene Mutation Analysis
  • LiquidHALLMARK Multi Cancer Panel
  • Mumps
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • Amylase, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Turnaround Time
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...